AI twice as accurate as a biopsy when grading severity of sarcomas by Jen Brogan | Nov 2, 2023 | News | 0 The new AI model could potentially be applied to other cancers Read More
PRIME status for Adaptimmune’s synovial sarcoma drug by Selina McKee | Jul 28, 2020 | News | 0 The drug has the potential to address an unmet need Read More